Vergleich

Naftopidil DiHCl Europäischer Partner

ArtNr S1387-500
Hersteller Selleckchem
CAS-Nr. 57149-08-3
Menge 500 mg
Quantity options 1 g 10 g 10 mM/1 ml 25 mg 50 mg 500 mg 5 g
Kategorie
Typ Inhibitors
Specific against other
Smiles COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O.Cl.Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Flivas,KT-611,Avishot,BM-15275
Similar products Naftopidil
Lieferbar
Manufacturer - Targets
TOP1
Storage Conditions
2 years -80 in solvent
Molecular Weight
465, 41
Administration
Orally
Animal Models
Athymic nude mice bearing PC-3 cells
Cell lines
LNCaP and PC-3 cell lines
Concentrations
20 uM, 40 uM
Dosages
10 mL/kg/day
Formulation
0.5% carboxymethylcellulose
IC50
0.1 uM, 0.1 uM, 0.1 uM, 0.1 uM, 0.1 uM, 0.1 uM
In vitro
Naftopidil diHCl possesses 5-HT1A agonistic properties in addition to being an alpha1-adrenoceptor antagonist. [1] Naftopidil has growth inhibitory effect in androgen-sensitive and -insensitive human prostate cancer cell lines. Naftopidil inhibits the growth of androgen-sensitive LNCaP cells and androgen-insensitive PC-3 cells with IC50 of 22.2 uM and 33.2 uM, respectively. Cell growth inhibition by Naftopidil is due to the arrest of the G1 cell cycle. Expressions of p27kip1 and p21cip1 are significantly increased in LNCaP cells treated with Naftopidil. In PC-3 cells, Naftopidil induces p21cip1 but not p27kip1. [2] Naftopidil produces a concentration-dependent inhibition of collagen-induced Ca2+ mobilization, maximum inhibition (22.9%) occurring with 40 uM Naftopidil. The adrenaline-induced rise in [Ca2+]i is inhibited dose dependently by Naftopidil. [3] Naftopidil is significantly more effective than tamsulosin in relieving nocturia. [4] Naftopidil induces G(1) cell-cycle arrest in both PCa cells and PrSC. In Naftopidil-treated PrSC, total interleukin-6 protein is significantly reduced with increased suppression of cell proliferation. [5]
In vivo
Oral administration of Naftopidil to nude mice inhibits the growth of PC-3 tumors as compared to vehicle-treated controls. Naftopidil improves bladder capacity and relaxed voiding via inhibition of afferent nerve activity. [2] Naftopidil (0.1 ug–30 ug) transiently abolishes isovolumetric rhythmic bladder contraction. The amplitude of bladder contraction is decreased by intrathecal injection of naftopidil (3 ug–30 ug). [6] Naftopidil selectively inhibits the phenylephrine-induced increase in prostatic pressure compared with mean blood pressure in the anesthetized dog model. [7]
Incubation Time
24 hours
Method
Cell cycle analysis is performed by flow cytometry. Cells are treated with either 20 uM Naftopidil (LNCaP), 40 uM Naftopidil (PC-3) or vehicle (0.1% DMSO) for 24 hours, then trypsinized and washed once with phosphate-buffer saline (PBS), fixed in 70% ethanol and stored at 4 C for subsequent cell cycle analysis. Fixed cells are washed with PBS and incubated with PBS containing 20 ug/mL RNaseA and 0.3% NP-40 for 30 minutes at 37 C, then stained with 50 ug/mL propidium iodide (PI) for 30 minutes at 4 C in the dark. The DNA content of 1 x 106 stained cells is analyzed on a FACS Caliburflow cytometer. The fractions of cells in the G0/G1, S and G2/M phases are calculated using Cell Quest software.
Solubility (25C)
DMSO 41 mg/mL, Water <1 mg/mL, Ethanol 2 mg/mL
Information
Naftopidil DiHCl (Flivas, KT-611, Avishot, BM-15275) is a selective 5-HT1A and α1-adrenergic receptor antagonist with IC50 of 0.1 μM and 0.2 μM, respectively.
Chemical Name
1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol dihydrochloride
Features
Higher selectivity for the -1A and -1D subtypes.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?